Value of determining carbohydrate-deficient transferrin isoforms in the diagnosis of alcoholic liver disease

Mayo Clinic Proceedings

Volumn 78, Issue 6, 2003, Pages 703-707

  Stadheim, Linda M ^a   O'Brien, John F ^a   Lindor, Keith D ^a   Gores, Gregory J ^a   McGill, Douglas B ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CARBOHYDRATE DEFICIENT TRANSFERRIN; TRANSFERRIN;

ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; AREA UNDER THE CURVE; ARTICLE; BIOCHEMICAL COMPOSITION; CONTROLLED STUDY; DENSITOMETRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR;

EID: 0038726950     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/78.6.703     Document Type: Article

References (33)

1. Bataille V, Ruidavets JB, Arveiler D, et al. Joint use of clinical parameters, biological markers and CAGE questionnaire for the identification of heavy drinkers in a large population-based sample. Alcohol Alcohol. 2003;38:121-127.
2. Sharpe PC, McBride R, Archbold GP. Biochemical markers of alcohol abuse. QJM. 1996;89:137-144.
3. Stibler H, Allgulander C, Borg S, Kjellin KG. Abnormal microheterogeneity of transferrin in serum and cerebrospinal fluid in alcoholism. Acta Med Scand. 1978;204:49-56.
4. Stibler H. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem. 1991;37:2029-2037.
5. Fletcher LM, Kwoh-Gain I, Powell EE, Powell LW, Halliday JW. Markers of chronic alcohol ingestion in patients with nonalcoholic steatohepatitis: an aid to diagnosis. Hepatology. 1991;13:455-459.
6. De Feo TM, Fargion S, Duca L, et al. Carbohydrate-deficient transferrin, a sensitive marker of chronic alcohol abuse, is highly influenced by body iron. Hepatology. 1999;29:658-663.
7. Laposata M. Assessment of ethanol intake: current tests and new assays on the horizon. Am J Clin Pathol. 1999;112:443-450.
8. Bell H, Tallaksen C, Sjaheim T, et al. Serum carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with chronic liver diseases. Alcohol Clin Exp Res. 1993;17:246-252.
9. Rublo M, Caballeria J, Deulofeu R, et al. Carbohydrate-deficient transferrin as a marker of alcohol consumption in male patients with liver disease. Alcohol Clin Exp Res. 1997;21:923-927.
10. Salaspuro M. Carbohydrate-deficient transferrin as compared to other markers of alcoholism: a systematic review. Alcohol. 1999;19:261-271.
11. Schmitt UM, Stieber P, Jungst D, et al. Carbohydrate-deficient transferrin is not a useful marker for the detection of chronic alcohol abuse. Eur J Clin Invest. 1998;28:615-621.
12. Henriksen JH, Gronbaek M, Moller S, Bendtsen F, Becker U. Carbohydrate deficient transferrin (CDT) in alcoholic cirrhosis: a kinetic study. J Hepatol. 1997;26:287-292.
13. Arndt T. Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation. Clin Chem. 2001;47:13-27.
14. Heggli DE, Aurebekk A, Granum B, Westby C, Lovli T, Sundrehagen E. Should tri-sialo-transferrins be included when calculating carbohydrate-deficient transferrin for diagnosing elevated alcohol intake? Alcohol Alcohol. 1996;31:381-384.
15. Bean P, Liegmann K, Lovli T, Westby C, Sundrehagen E. Semiautomated procedures for evaluation of carbohydrate-deficient transferrin in the diagnosis of alcohol abuse. Clin Chem. 1997;43(6, pt 1):983-989.
16. Gordon HM, Morgan MY. Serum carbohydrate deficient transferrin (CDT): comparison of measurement techniques [abstract]. Gut. 1998;43:157.
17. Gordon N. Carbohydrate-deficient glycoprotein syndromes. Postgrad Med J. 2000;76:145-149.
18. Patterson MC. Screening for "prelysosomal disorders": carbohydrate-deficient glycoprotein syndromes. J Child Neurol. 1999;14(suppl 1):S16-S22.
19. de Lonlay P, Cormier-Daire V, Vuillaumier-Barrot S, et al. Carbohydrate-deficient blood glycoprotein syndrome [in French]. Arch Pediatr. 2000;7:173-184.
20. van Ommen CH, Peters M, Barth PG, Vreken P, Wanders RJ, Jaeken J. Carbohydrate-deficient glycoprotein syndrome type 1a: a variant phenotype with borderline cognitive dysfunction, cerebellar hypoplasia, and coagulation disturbances. J Pediatr. 2000;136:400-403.
21. Stibler H, Hultcrantz R. Carbohydrate-deficient transferrin in serum in patients with liver diseases. Alcohol Clin Exp Res. 1987;11:468-473.
22. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine [published correction appears in Clin Chem. 1993;39:1589]. Clin Chem. 1993;39:561-577.
23. Van Eijk HG, Van Noort WL. Isolation of rat transferrin using CNBr-activated sepharose 4B. J Clin Chem Clin Biochem. 1976;14:475-478.
24. Stibler H, Jaecken J. Carbohydrate deficient serum transferrin in a new systemic hereditary syndrome. Arch Dis Child. 1990;65:107-111.
25. Lieber CS. Carbohydrate deficient transferrin in alcoholic liver disease: mechanisms and clinical implications. Alcohol. 1999;19:249-254.
26. Randell E, Diamandis EP, Goldberg DM. Changes in serum carbohydrate-deficient transferrin and gammaglutamyl transferase after moderate wine consumption in healthy males. J Clin Lab Anal. 1998;12:92-97.
27. Caldwell SH, Halliday JW, Fletcher LM, et al. Carbohydratedeficient transferrin in alcoholics with liver disease. J Gastroenterol Hepatol. 1995;10:174-178.
28. Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol. 1999;94:1018-1022.
29. Allen JP, Cross GM, Fertig JB, Litten RZ. Screening for alcohol problems in the military: recommended tests. Mil Med. 1998;163:9-12.
30. Hermansson U, Helander A, Huss A, Brandt L, Ronnberg S. The Alcohol Use Disorders Identification Test (AUDIT) and carbohydrate-deficient transferrin (CDT) in a routine workplace health examination. Alcohol Clin Exp Res. 2000;24:180-187.
31. Heinemann A, Sterneck M, Kuhlencordt R, et al. Carbohydratedeficient transferrin: diagnostic efficiency among patients with end-stage liver disease before and after liver transplantation. Alcohol Clin Exp Res. 1998;22:1806-1812.
32. Berlakovich GA, Windhager T, Fruendorfer E, Lesch OM, Steininger R, Muhlbacher F. Carbohydrate deficient transferrin for detection of alcohol relapse after orthotopic liver transplantation for alcoholic cirrhosis. Transplantation. 1999;67:1231-1235.
33. Sillanaukee P, Massot N, Jousilahti P, et al. Dose response of laboratory markers to alcohol consumption in a general population. Am J Epidemiol. 2000;152:747-751.